Immunemodulation in Patients With Minor Head Injury

Medical University of Vienna130 enrolled

Overview

The purpose of this study is to try to prove the worth of the two (2) Serum Proteins S-100 Beta and NSE in combination with a diagnostic algorithm to help to establish diagnosis in patients with minor head injury.

Study Type

OBSERVATIONAL

Enrollment

130

Conditions

Head Trauma

Eligibility

Sex: ALLMin age: 1 Year

Medical Language ↔ Plain English

Inclusion Criteria: * minor head injury Exclusion Criteria: * severe head injury

Locations (1)

Medical University of Vienna

Vienna, State of Vienna, Austria

Outcomes

Primary Outcomes

Intracranial Haematoma

Time frame: 2 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.